Comparison of two toxins produced by Clostridium difficile

Clostridium difficile was shown to produce a toxin which could be biochemically separated from the previously described cytotoxin of the same organism. The two proteins differ in biological activity and physical properties. Antiserum prepared to the second toxin does not neutralize the biological activity of the cytotoxin, and immunological cross-reactivity could not be demonstrated. However, some relationship may exist between the two toxins, since the newly described toxin degrades on polyacrylamide electrophoresis into two molecules, one of which appears to migrate with the band of purified cytotoxin. We suggest that this newly described toxin be designated toxin A until its primary biological activity and physical relationship to cytotoxin is determined. This toxin is active in biological assays of enteric disease and may play an important role in C. difficile-induced colitis.

[1]  H. Sugiyama.  Clostridium botulinum neurotoxin. , 1980, Microbiological reviews.

[2]  M. Ehrich,et al.  Production of Clostridium difficile antitoxin , 1980, Infection and immunity.

[3]  S. Finegold,et al.  Purification and characterization of Clostridium difficile toxin , 1979, Infection and immunity.

[4]  J. Bartlett,et al.  Partial purification and characterization of a cytotoxin from Clostridium difficile. , 1979, Reviews of infectious diseases.

[5]  M. Keighley,et al.  Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea. , 1978, British medical journal.

[6]  J. Bartlett,et al.  Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. , 1978, Gastroenterology.

[7]  A. Price,et al.  CLOSTRIDIUM DIFFICILE AND THE ÆTIOLOGY OF PSEUDOMEMBRANOUS COLITIS , 1978, The Lancet.

[8]  C. Humphrey,et al.  Partial purification of a toxin found in hamsters with antibiotic-associated colitis. Reversible binding of the toxin by cholestyramine. , 1978, Gastroenterology.

[9]  J. Bartlett,et al.  Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients , 1978, Infection and immunity.

[10]  M. Keighley,et al.  Identification of Clostridium difficile as a cause of pseudomembranous colitis. , 1978, British medical journal.

[11]  J. Bartlett,et al.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. , 1978, The New England journal of medicine.

[12]  A. Price,et al.  PSEUDOMEMBRANOUS COLITIS: PRESENCE OF CLOSTRIDIAL TOXIN , 1977, The Lancet.

[13]  R. Sack,et al.  ANTIBIOTIC-INDUCED COLITIS IMPLICATION OF A TOXIN NEUTRALISED BY CLOSTRIDIUM SORDELLII ANTITOXIN , 1977, The Lancet.

[14]  J. Bartlett,et al.  Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. , 1977, The Journal of infectious diseases.

[15]  P. Cuatrecasas,et al.  A simplified method for cyanogen bromide activation of agarose for affinity chromatography. , 1974, Analytical biochemistry.

[16]  A. Dean,et al.  Test for Escherichia coli enterotoxin using infant mice: application in a study of diarrhea in children in Honolulu. , 1972, The Journal of infectious diseases.

[17]  K. Weber,et al.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. , 1969, The Journal of biological chemistry.

[18]  J. Craig.  A Permeability Factor (Toxin) Found in Cholera Stools and Culture Filtrates and its Neutralization by Convalescent Cholera Sera , 1965, Nature.

[19]  B. Davis.  DISC ELECTROPHORESIS – II METHOD AND APPLICATION TO HUMAN SERUM PROTEINS * , 1964, Annals of the New York Academy of Sciences.

[20]  S. De.  Enterotoxicity of Bacteria-free Culture-filtrate of Vibrio cholerae , 1959, Nature.

[21]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[22]  M. Sterne,et al.  A new method for the large-scale production of high-titre botulinum formol-toxoid types C and D. , 1950, Journal of immunology.

[23]  E. Goldstein,et al.  Aetiology of antimicrobial-agent-associated colitis. , 1978, Lancet.